Answer:
Malignant hyperthermia
Explanation:
Malignant hyperthermia is a syndrome of genetic origin, where susceptible individuals, when exposed to certain anesthetics (especially inhalers) develop a hypermetabolic condition characterized by increased muscle temperature faster than core temperature. Failure to treat the symptoms immediately can result in death. It was first described in Australia in the year 1960 by Denborough and Lowell, later other cases were described in Wisconsin and Toronto.
Malignant hyperthermia occurs in most cases due to mutation of a calcium channel of skeletal muscles. This mutation may result in exacerbated calcium release in the muscle when some anesthetics are present. This can result in the destruction of skeletal muscle fiber. As there is a high energy consumption, increased CO2 production and rapid increase in body temperature, with biochemical and hematological consequences, there may also be the evolution to irreversible shock and cardiovascular collapse.
<span>The correct answer is
A. heredity </span>
Answer: 67904-E1
Response Feedback:
Rationale: In the CPT Index look for
Blepharoptosis /Repair/Tarso Levator Resection/
Advancement/ External Approach. You are referred to 67904. Review the code in the numeric section to verify acuracy. This is the correct code because the external approach of cutting the skin of the eyelid was performed and dissection is carried to the levator tendon. The provider uses sutures to advance the levator tendon to create a new eyelid crease.Append modifier E1 for upper left, eyelid.
